Physician profile
Warren E Lichliter
NPI 1639249253
$10,887.56
in general payments reported to CMS, 2019-2025
50 companies · $1,425 in 2025
The $1,425 reported for 2025 was more than what 77% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,387 · 2020: $1,044 · 2021: $1,702 · 2022: $1,724 · 2023: $1,555 · 2024: $2,050 · 2025: $1,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,030.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $2,849.00 | 2019-2025 | Entyvio, Gattex |
| Abbvie INC. | $2,332.51 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $598.78 | 2019-2024 | Dificid, Zerbaxa |
| Organon LLC | $526.50 | 2021-2025 | Renflexis, Hadlima |
| Stryker Corporation | $354.98 | 2019-2021 | |
| Medtronic, INC. | $334.57 | 2021-2025 | Ligasure, Interstim, Signia |
| Janssen Biotech, INC. | $308.79 | 2022-2025 | Tremfya, Stelara |
| Lilly USA, LLC | $257.28 | 2024-2025 | Omvoh |
| Pfizer INC. | $252.35 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $248.48 | 2019-2025 | Xifaxan |
| Aimmune Therapeutics, INC. | $235.98 | 2024-2025 | Vowst |
| Ethicon US, LLC | $200.80 | 2020-2025 | Echelon Circular, Echelon Endopath, Echelon Flex |
| Tela Bio, INC. | $191.44 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Braintree Laboratories, INC. | $166.20 | 2019-2023 | Suflave |
| Shire North American Group INC | $165.89 | 2019 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Lichliter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.